Filing Details

Accession Number:
0001140361-10-034501
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-08-20 14:00:43
Reporting Period:
2010-08-18
Filing Date:
2010-08-20
Accepted Time:
2010-08-20 14:00:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
812796 Soligenix Inc. SNGX Pharmaceutical Preparations (2834) 411505029
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1433766 Hal Mintz 1 Liberty Plaza, 27Th Floor
New York NY 10006
No No Yes No
1433767 Ross Berman 1 Liberty Plaza, 27Th Floor
New York NY 10006
No No Yes No
1463541 Bam Management Llc 1 Liberty Plaza, 27Th Floor
New York NY 10006
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-08-18 160,000 $0.24 21,766,092 No 4 P Indirect See Footnotes
Common Stock Disposition 2010-08-18 192,314 $0.24 21,573,778 No 4 S Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnotes
No 4 S Indirect See Footnotes
Footnotes
  1. The price reported is a weighted average.
  2. The reported securities are held by investment funds for which BAM Management, LLC serves as investment manager. Mr. Hal Mintz and Mr. Ross Berman serve as managing members of BAM Management, LLC. In their respective capacities, each of BAM Management, LLC, Mr. Hal Mintz and Mr. Ross Berman may be deemed to beneficially own the reported securities.
  3. Each of the reporting persons disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.